Terrence C. Kearney's Insider Trades & SAST Disclosures

Terrence C. Kearney's most recent trade in Vertex Pharmaceuticals, Inc. was a trade of 3,142 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2024.

Share

Note

This is a custom search result for pattern Terrence C. Kearney.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2024	3,142	3,142	-		-	Stock Option (Right to Buy)
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Sale of securities on an exchange or to another person at price $ 350.00 per share.	10 Aug 2023	10,000	6,536 (0%)	0%	350	3,500,000	Common Stock
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.54 per share.	10 Aug 2023	10,000	16,536 (0%)	0%	127.5	1,275,400	Common Stock
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2023	10,000	10,000	-		-	Stock Option (Right to Buy)
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2023	3,481	3,481	-		-	Stock Option (Right to Buy)
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2022	2,231	2,231	-		-	Stock Option (Right to Buy)
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2022	725	6,536 (0%)	0%		0	Common Stock
Vertex Pharma Results Board Meeting	Terrence C. Kearney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2021	6,067	6,067	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades